SplitJul 21, 2026, 08:50 PM
Picard Medical Announces 1-for-50 Reverse Stock Split for NYSE Compliance
AI Summary
Picard Medical, Inc. announced its Board of Directors approved a 1-for-50 reverse stock split of its common stock. This action is intended to support the company's continued compliance with NYSE American listing standards. The split is expected to become effective on July 31, 2026, with split-adjusted trading commencing on August 3, 2026. Interim CEO Richard Fang stated the split is an important step for continued listing and positioning the company for its next phase of growth.
Key Highlights
- Picard Medical's Board approved a 1-for-50 reverse stock split.
- The split aims to support continued compliance with NYSE American listing standards.
- Stockholders approved an amendment authorizing a split ratio of 1-for-15 to 1-for-50.
- The Reverse Stock Split is expected to be effective at 5:00 p.m. ET on July 31, 2026.
- Common stock will begin trading on a split-adjusted basis on August 3, 2026.
- No fractional shares will be issued; shares will be rounded up to the nearest whole share.
- The split will proportionately adjust outstanding equity awards, warrants, and convertible securities.
Price Impact
More from PMI